The Recall Desk
ModerateFDA (Drugs)·D-0807-2020·Announced 2020-02-05

Medical Park Pharmacy Recalls Liothyronine Capsules Due to Expired Components

MPRX, Inc. dba Medical Park Pharmacy is recalling Liothyronine (T3) 80 mcg SR capsules compounded with expired components and missing labeling.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves labeling errors and the use of expired components, which fits the criteria for moderate severity involving minor labeling errors or low-risk contamination without reported injuries.

Plain-English summary

MPRX, Inc. dba Medical Park Pharmacy is recalling five bottles of Liothyronine (T3) 80 mcg SR capsules. The recall is due to incorrect or missing lot and expiration date labeling, and the products were compounded using expired components.

The affected product is identified by Lot 61253:42 with a use-by date of 04/01/2020. The recall is limited to distribution in Texas.

Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on disposal or replacement.

The recalled product

Product
Liothyronine (T3) 80 mcg SR cap
Affected units
5

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot: 61253:42 Use by: 04/01/2020

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 18 recalled by MPRX, Inc. dba Medical Park Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 18 products in this recall →